130 related articles for article (PubMed ID: 34247482)
1. Characterizing Cutaneous Drug Delivery Using Open-Flow Microperfusion and Mass Spectrometry Imaging.
Handler AM; Eirefelt S; Lambert M; Johansson F; Hollesen Schefe L; Østergaard Knudsen N; Bodenlenz M; Birngruber T; Sinner F; Huss Eriksson A; Pommergaard Pedersen G; Janfelt C; Troensegaard Nielsen K
Mol Pharm; 2021 Aug; 18(8):3063-3072. PubMed ID: 34247482
[TBL] [Abstract][Full Text] [Related]
2. Quantitative MALDI mass spectrometry imaging for exploring cutaneous drug delivery of tofacitinib in human skin.
Handler AM; Pommergaard Pedersen G; Troensegaard Nielsen K; Janfelt C; Just Pedersen A; Clench MR
Eur J Pharm Biopharm; 2021 Feb; 159():1-10. PubMed ID: 33352255
[TBL] [Abstract][Full Text] [Related]
3. MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles.
Bonnel D; Legouffe R; Eriksson AH; Mortensen RW; Pamelard F; Stauber J; Nielsen KT
Anal Bioanal Chem; 2018 Apr; 410(11):2815-2828. PubMed ID: 29546543
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology.
Kushner J; Lamba M; Stock T; Wang R; Nemeth MA; Alvey C; Chen R; DeMatteo V; Blanchard A
Eur J Pharm Sci; 2020 Apr; 147():105200. PubMed ID: 31863865
[TBL] [Abstract][Full Text] [Related]
5. MALDI mass spectrometry imaging as a complementary analytical method for improved skin distribution analysis of drug molecule and excipients.
Handler AM; Fallah M; Just Pedersen A; Pommergaard Pedersen G; Troensegaard Nielsen K; Janfelt C
Int J Pharm; 2020 Nov; 590():119949. PubMed ID: 33035610
[TBL] [Abstract][Full Text] [Related]
6. Fractional laser-assisted topical delivery of bleomycin quantified by LC-MS and visualized by MALDI mass spectrometry imaging.
Hendel KK; Bagger C; Olesen UH; Janfelt C; Hansen SH; Haedersdal M; Lerche CM
Drug Deliv; 2019 Dec; 26(1):244-251. PubMed ID: 30859849
[TBL] [Abstract][Full Text] [Related]
7. Combination of MALDI-MSI and cassette dosing for evaluation of drug distribution in human skin explant.
Sørensen IS; Janfelt C; Nielsen MMB; Mortensen RW; Knudsen NØ; Eriksson AH; Pedersen AJ; Nielsen KT
Anal Bioanal Chem; 2017 Aug; 409(21):4993-5005. PubMed ID: 28687883
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Mass Spectrometry Imaging to Study Drug Distribution in the Intestine Following Oral Dosing.
Huizing LRS; McDuffie J; Cuyckens F; van Heerden M; Koudriakova T; Heeren RMA; Vreeken RJ
Anal Chem; 2021 Feb; 93(4):2144-2151. PubMed ID: 33470103
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.
Bodenlenz M; Dragatin C; Liebenberger L; Tschapeller B; Boulgaropoulos B; Augustin T; Raml R; Gatschelhofer C; Wagner N; Benkali K; Rony F; Pieber T; Sinner F
Pharm Res; 2016 Sep; 33(9):2229-38. PubMed ID: 27271272
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Dermal Pharmacokinetics and Pharmacodymanic Effect of Soft Topical PDE4 Inhibitors: Open Flow Microperfusion and Skin Biopsies.
Eirefelt S; Hummer J; Basse LH; Bertelsen M; Johansson F; Birngruber T; Sinner F; Larsen J; Nielsen SF; Lambert M
Pharm Res; 2020 Nov; 37(12):243. PubMed ID: 33188482
[TBL] [Abstract][Full Text] [Related]
11. Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial.
Mukherjee A; Hazra A; Smith MK; Martin SW; Mould DR; Su C; Niezychowski W
Br J Clin Pharmacol; 2018 Jun; 84(6):1136-1145. PubMed ID: 29377257
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Krishnaswami S; Boy M; Chow V; Chan G
Clin Pharmacol Drug Dev; 2015 Mar; 4(2):83-8. PubMed ID: 27128212
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis.
Vong C; Martin SW; Deng C; Xie R; Ito K; Su C; Sandborn WJ; Mukherjee A
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):229-240. PubMed ID: 33513294
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Human and Porcine Skin in Laser-Assisted Drug Delivery of Chemotherapeutics.
Rosenberg LK; Bagger C; Janfelt C; Haedersdal M; Olesen UH; Lerche CM
Lasers Surg Med; 2021 Jan; 53(1):162-170. PubMed ID: 33161610
[TBL] [Abstract][Full Text] [Related]
15. The effect of mild and moderate hepatic impairment on the pharmacokinetics of tofacitinib, an orally active Janus kinase inhibitor.
Lawendy N; Lamba M; Chan G; Wang R; Alvey CW; Krishnaswami S
Clin Pharmacol Drug Dev; 2014 Nov; 3(6):421-7. PubMed ID: 27129117
[TBL] [Abstract][Full Text] [Related]
16. Proposome for transdermal delivery of tofacitinib.
Kathuria H; Nguyen DTP; Handral HK; Cai J; Cao T; Kang L
Int J Pharm; 2020 Jul; 585():119558. PubMed ID: 32565283
[TBL] [Abstract][Full Text] [Related]
17. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
18. Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake.
Wenande E; Olesen UH; Nielsen MM; Janfelt C; Hansen SH; Anderson RR; Haedersdal M
Expert Opin Drug Deliv; 2017 Mar; 14(3):307-317. PubMed ID: 27835937
[TBL] [Abstract][Full Text] [Related]
19. Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion.
Bodenlenz M; Augustin T; Birngruber T; Tiffner KI; Boulgaropoulos B; Schwingenschuh S; Raney SG; Rantou E; Sinner F
Pharm Res; 2020 Sep; 37(10):204. PubMed ID: 32989514
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis.
Bagherani N; Smoller BR
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
